Logo image of KRUS

KURA SUSHI USA INC-CLASS A (KRUS) Stock Fundamental Analysis

NASDAQ:KRUS - Nasdaq - US5012701026 - Common Stock - Currency: USD

69.85  -4.19 (-5.66%)

After market: 69.85 0 (0%)

Fundamental Rating

4

Taking everything into account, KRUS scores 4 out of 10 in our fundamental rating. KRUS was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. While KRUS has a great health rating, there are worries on its profitability. KRUS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KRUS had negative earnings in the past year.
In the past year KRUS had a positive cash flow from operations.
KRUS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: KRUS reported negative operating cash flow in multiple years.
KRUS Yearly Net Income VS EBIT VS OCF VS FCFKRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.91%, KRUS is doing worse than 71.76% of the companies in the same industry.
Looking at the Return On Equity, with a value of -3.39%, KRUS is in line with its industry, outperforming 47.33% of the companies in the same industry.
Industry RankSector Rank
ROA -1.91%
ROE -3.39%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
KRUS Yearly ROA, ROE, ROICKRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

KRUS has a Gross Margin of 19.40%. This is amonst the worse of the industry: KRUS underperforms 87.02% of its industry peers.
In the last couple of years the Gross Margin of KRUS has declined.
KRUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
KRUS Yearly Profit, Operating, Gross MarginsKRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

8

2. Health

2.1 Basic Checks

KRUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KRUS has more shares outstanding
Compared to 5 years ago, KRUS has more shares outstanding
KRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KRUS Yearly Shares OutstandingKRUS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
KRUS Yearly Total Debt VS Total AssetsKRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

KRUS has an Altman-Z score of 3.55. This indicates that KRUS is financially healthy and has little risk of bankruptcy at the moment.
KRUS has a Altman-Z score of 3.55. This is amongst the best in the industry. KRUS outperforms 80.92% of its industry peers.
KRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.55
ROIC/WACCN/A
WACC9.45%
KRUS Yearly LT Debt VS Equity VS FCFKRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.47 indicates that KRUS has no problem at all paying its short term obligations.
KRUS's Current ratio of 3.47 is amongst the best of the industry. KRUS outperforms 96.18% of its industry peers.
KRUS has a Quick Ratio of 3.40. This indicates that KRUS is financially healthy and has no problem in meeting its short term obligations.
KRUS's Quick ratio of 3.40 is amongst the best of the industry. KRUS outperforms 96.95% of its industry peers.
Industry RankSector Rank
Current Ratio 3.47
Quick Ratio 3.4
KRUS Yearly Current Assets VS Current LiabilitesKRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

KRUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -584.62%.
KRUS shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.68%.
Measured over the past years, KRUS shows a very strong growth in Revenue. The Revenue has been growing by 29.94% on average per year.
EPS 1Y (TTM)-584.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
Revenue 1Y (TTM)25.68%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%25.22%

3.2 Future

KRUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.09% yearly.
Based on estimates for the next years, KRUS will show a very strong growth in Revenue. The Revenue will grow by 20.64% on average per year.
EPS Next Y110.58%
EPS Next 2Y55.67%
EPS Next 3Y47.09%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y19.82%
Revenue Next 3Y20.64%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
KRUS Yearly Revenue VS EstimatesKRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
KRUS Yearly EPS VS EstimatesKRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRUS. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 226.01, the valuation of KRUS can be described as expensive.
Based on the Price/Forward Earnings ratio, KRUS is valued a bit more expensive than 69.47% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. KRUS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 226.01
KRUS Price Earnings VS Forward Price EarningsKRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200

4.2 Price Multiples

KRUS's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. KRUS is more expensive than 87.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 193.44
KRUS Per share dataKRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as KRUS's earnings are expected to grow with 47.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.67%
EPS Next 3Y47.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KRUS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KURA SUSHI USA INC-CLASS A

NASDAQ:KRUS (2/21/2025, 8:00:02 PM)

After market: 69.85 0 (0%)

69.85

-4.19 (-5.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)01-07 2025-01-07/amc
Earnings (Next)04-02 2025-04-02/amc
Inst Owners77.87%
Inst Owner Change10.51%
Ins Owners6.84%
Ins Owner Change1.1%
Market Cap843.09M
Analysts78.67
Price Target115.39 (65.2%)
Short Float %21.89%
Short Ratio8.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13205.6%
Min EPS beat(2)-26473.1%
Max EPS beat(2)61.93%
EPS beat(4)1
Avg EPS beat(4)-6671.73%
Min EPS beat(4)-26473.1%
Max EPS beat(4)61.93%
EPS beat(8)4
Avg EPS beat(8)-3334.29%
EPS beat(12)7
Avg EPS beat(12)-2193.03%
EPS beat(16)11
Avg EPS beat(16)-1640.89%
Revenue beat(2)2
Avg Revenue beat(2)1.59%
Min Revenue beat(2)0.8%
Max Revenue beat(2)2.38%
Revenue beat(4)2
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)2.38%
Revenue beat(8)3
Avg Revenue beat(8)-0.59%
Revenue beat(12)5
Avg Revenue beat(12)-0.31%
Revenue beat(16)8
Avg Revenue beat(16)1.86%
PT rev (1m)8%
PT rev (3m)8.12%
EPS NQ rev (1m)-4.17%
EPS NQ rev (3m)-383.79%
EPS NY rev (1m)197.06%
EPS NY rev (3m)127.43%
Revenue NQ rev (1m)-0.75%
Revenue NQ rev (3m)-8%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 226.01
P/S 3.36
P/FCF N/A
P/OCF 48.05
P/B 3.7
P/tB 3.7
EV/EBITDA 193.44
EPS(TTM)-0.63
EYN/A
EPS(NY)0.31
Fwd EY0.44%
FCF(TTM)-2.47
FCFYN/A
OCF(TTM)1.45
OCFY2.08%
SpS20.78
BVpS18.85
TBVpS18.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -3.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.4%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 382.8%
Cap/Sales 18.9%
Interest Coverage N/A
Cash Conversion 461.49%
Profit Quality N/A
Current Ratio 3.47
Quick Ratio 3.4
Altman-Z 3.55
F-Score4
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)464%
Cap/Depr(5y)432.88%
Cap/Sales(3y)20.03%
Cap/Sales(5y)22.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-584.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
EPS Next Y110.58%
EPS Next 2Y55.67%
EPS Next 3Y47.09%
EPS Next 5YN/A
Revenue 1Y (TTM)25.68%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%25.22%
Revenue Next Year19.34%
Revenue Next 2Y19.82%
Revenue Next 3Y20.64%
Revenue Next 5YN/A
EBIT growth 1Y-2345.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year443.03%
EBIT Next 3Y105.84%
EBIT Next 5YN/A
FCF growth 1Y-75.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.64%
OCF growth 3YN/A
OCF growth 5Y21.12%